Violacein extracted from Chromobacterium violaceum inhibits Plasmodium growth in vitro and in vivo

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 5, 2009, Pages 2149-2152

  Lopes, Stefanie C P ^a   Blanco, Yara C ^a   Justo, Giselle Z ^b   Nogueira, Paulo A ^c,e   Rodrigues, Francisco L S ^c   Goelnitz, Uta ^d   Wunderlich, Gerhard ^d   Facchini, Gustavo ^a   Brocchi, Marcelo ^a   Duran, Nelson ^a   Costa, Fabio T M ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c BR 364   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e INSTITUTO LEÔNIDAS E MARIA DEANE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; PIGMENT; UNCLASSIFIED DRUG; VIOLACEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMALARIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROTOZOAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CHROMOBACTERIUM VIOLACEUM; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PARASITEMIA; PLASMODIUM; PLASMODIUM CHABAUDI; PLASMODIUM CHABAUDI CHABAUDI; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; TREATMENT RESPONSE;

ANIMALS; ANTIMALARIALS; CHLOROQUINE; CHROMOBACTERIUM; DRUG RESISTANCE; HUMANS; INDOLES; MALARIA; MALARIA, FALCIPARUM; MICE; MICE, INBRED C57BL; PARASITEMIA; PARASITIC SENSITIVITY TESTS; PLASMODIUM CHABAUDI; PLASMODIUM FALCIPARUM; TREATMENT OUTCOME;

EID: 66149155804     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00693-08     Document Type: Article

References (16)

1. de Carvalho, D. D., F. T. M. Costa, N. Duran, and M. Haun. 2006. Cytotoxic activity of violacein in human colon cancer cells. Toxicol. In Vitro 20:1514-1521. (Pubitemid 44537664)
2. di Santi, S. M., M. Boulos, M. A. Vasconcelos, S. Oliveira, A. Couto, and V. E. Rosário. 1987. Characterization of Plasmodium falciparum strains of the State of Rondonia, Brazil, using microtests of sensitivity to antimalarials, enzyme typing and monoclonal antibodies. Rev. Inst. Med. Trop. Sao Paulo 29:142-147.
3. Durán, N., V. Campos, R. Riveros, A. Joyas, M. F. Pereira, and M. Haun. 1989. Bacterial chemistry. III. Preliminary studies on trypanosomal activities of Chromobacterium violaceum products. An. Acad. Bras. Cienc. 61:31-36.
4. Durán, N., and C. F. Menck. 2001. Chromobacterium violaceum: a review of pharmacological and industrial perspectives. Crit. Rev. Microbiol. 27:201-222.
5. Durán, N., G. Z. Justo, C. V. Ferreira, P. S. Melo, L. Cordi, and D. Martins. 2007. Violacein: properties and biological activities. Biotechnol. Appl. Biochem. 48:127-133. (Pubitemid 350304758)
6. Fernandez, V. 2004. Sorbitol-synchronization of Plasmodium falciparum-infected erythrocytes, p. 24. In I. Ljungström, H. Perlmann, M. Schlichtherle, A. Scherf, and M. Wahlgren (ed.), Methods in malaria research, 4th ed. MR4/ATCC, Manassas, VA.
7. Ferreira, C. V., C. L. Bos, H. H. Versteeg, G. Z. Justo, N. Duran, and M. P. Peppelenbosch. 2004. Molecular mechanism of violacein-mediated human leukemia cell death. Blood 104:1459-1464. (Pubitemid 39166525)
8. Kodach, L. L., C. L. Bos, N. Duran, M. P. Peppelenbosch, C. V. Ferreira, and J. C. Hardwick. 2006. Violacein synergistically increases 5-fluorouracil cytotoxicity, induces apoptosis and inhibits Akt-mediated signal transduction in human colorectal cancer cells. Carcinogenesis 27:508-516. (Pubitemid 43372880)
9. Leon, L. L., C. C. Miranda, A. O. De Souza, and N. Duran. 2001. Antileishmanial activity of the violacein extracted from Chromobacterium violaceum. J. Antimicrob. Chemother. 48:449-450. (Pubitemid 32898824)
10. Melo, P. S., G. Z. Justo, M. B. de Azevedo, N. Duran, and M. Haun. 2003. Violacein and its β-cyclodextrin complexes induce apoptosis and differentiation in HL60 cells. Toxicology 186:217-225. (Pubitemid 36293798)
11. Melo, P. S., S. S. Maria, B. C. Vidal, M. Haun, and N. Duran. 2000. Violacein cytotoxicity and induction of apoptosis in V79 cells. In Vitro Cell Dev. Biol. Anim. 36:539-543.
12. Rettori, D., and N. Durán. 1998. Production, extraction and purification of violacein: an antibiotic produced by Chromobacterium violaceum. World J. Microbiol. Biotechnol. 14:685-688.
13. 3H-hypoxanthine incorporation assay for the study of growth inhibition by drugs, p. 87-89. In I. Ljungström, H. Perlmann, M. Schlichtherle, A. Scherf, and M. Wahlgren (ed.), Methods in malaria research, 4th ed. MR4/ATCC, Manassas, VA.
14. Snounou, G., A. C. Grüner, C. D. Müller-Graf, D. Mazier, and L. Rénia. 2005. The Plasmodium sporozoite survives RTS,S vaccination. Trends Parasitol. 21:456-461.
15. Talisuna, A.O., P. E Okello, A. Erhart, M. Coosemans, and U. D'Alessandro. 2007. Intensity of malaria transmission and the spread of Plasmodium falciparum resistant malaria: a review of epidemiologic field evidence. Am. J. Trop. Med. Hyg. 77:170-180.
16. Walliker, D., I. A. Quakyi, T. E. Wellems, T. F. McCutchan, A. Szarfman, W. T. London, L. M. Corcoran, T. R. Burkot, and R. Carter. 1987. Genetic analysis of the human malaria parasite Plasmodium falciparum. Science 236:1661-1666.